IRIS
DE SANCTIS, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.919
AS - Asia 2.636
EU - Europa 995
SA - Sud America 902
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 137
OC - Oceania 9
Totale 8.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.799
SG - Singapore 1.477
BR - Brasile 756
CN - Cina 466
VN - Vietnam 374
IT - Italia 328
FI - Finlandia 139
IE - Irlanda 114
DE - Germania 84
CA - Canada 69
FR - Francia 69
NG - Nigeria 69
AR - Argentina 61
HK - Hong Kong 61
GB - Regno Unito 54
IN - India 49
TR - Turchia 43
NL - Olanda 35
SE - Svezia 34
MX - Messico 32
BD - Bangladesh 29
RU - Federazione Russa 28
EC - Ecuador 26
IQ - Iraq 24
ES - Italia 21
ZA - Sudafrica 21
ID - Indonesia 18
IL - Israele 16
MA - Marocco 16
BE - Belgio 15
CL - Cile 14
CO - Colombia 14
UA - Ucraina 12
JP - Giappone 11
EU - Europa 10
PY - Paraguay 10
EG - Egitto 9
PL - Polonia 9
VE - Venezuela 9
AU - Australia 7
CZ - Repubblica Ceca 7
PK - Pakistan 7
RO - Romania 7
SA - Arabia Saudita 7
IR - Iran 6
NP - Nepal 6
KE - Kenya 5
PE - Perù 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
GR - Grecia 4
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
SN - Senegal 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AT - Austria 3
BO - Bolivia 3
BW - Botswana 3
ET - Etiopia 3
HN - Honduras 3
KZ - Kazakistan 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
TT - Trinidad e Tobago 3
AM - Armenia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
JE - Jersey 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
MN - Mongolia 1
MR - Mauritania 1
NI - Nicaragua 1
PA - Panama 1
Totale 8.609
Salva come PNG Salva come JPEG
Città #
Singapore 622
Wilmington 467
Ashburn 304
Chandler 232
The Dalles 222
San Jose 183
Shanghai 174
San Mateo 172
Dallas 169
Ann Arbor 166
Helsinki 139
Council Bluffs 135
New York 123
Ho Chi Minh City 119
Beijing 118
Dublin 114
Milan 109
Leawood 101
Hanoi 95
Boardman 91
Princeton 89
Lawrence 85
São Paulo 71
Benin City 67
Hong Kong 58
Fairfield 56
Paris 53
Santa Clara 48
Woodbridge 44
Toronto 43
Los Angeles 42
Rio de Janeiro 37
Rome 37
Kocaeli 31
Amsterdam 27
London 26
Phoenix 25
Seattle 20
Assago 16
Brussels 15
Orem 15
Atlanta 13
Buffalo 13
Curitiba 13
Da Nang 13
Hải Dương 13
Naples 13
Brasília 12
Brooklyn 12
Cincinnati 12
Guayaquil 12
Haiphong 12
Monmouth Junction 12
Montreal 12
Chennai 11
Figino 11
Mexico City 11
Buenos Aires 10
Fortaleza 10
Johannesburg 10
Munich 10
Recife 10
Tokyo 10
Biên Hòa 9
Chicago 9
Porto Alegre 9
Baghdad 8
Bradenton 8
Houston 8
Miami 8
Falkenstein 7
Natal 7
Pune 7
Quito 7
San Diego 7
Belo Horizonte 6
Brno 6
Casablanca 6
Dhaka 6
Erbil 6
Hillsboro 6
Manaus 6
New Delhi 6
Newark 6
Norwalk 6
Osasco 6
Salvador 6
San Francisco 6
Santiago 6
Warsaw 6
Abbiategrasso 5
Asunción 5
Bari 5
Bergamo 5
Bắc Ninh 5
Cachoeirinha 5
Cairo 5
Campinas 5
Franca 5
Frankfurt am Main 5
Totale 5.249
Salva come PNG Salva come JPEG
Nome #
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 123
Biological characteristics and long-term outcomes in node-negative breast cancer 122
Treatment of malignant pleural mesothelioma: current status and future directions 122
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 114
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 112
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 110
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 108
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 108
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 108
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 107
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 106
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 105
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 105
Imatinib mesylate in desmoplastic small round cell tumour 103
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 99
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 95
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 94
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 94
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 92
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 90
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 90
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 90
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 89
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 89
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 86
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 86
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 85
A pilot analysis of headache disorders in breast cancer patients 85
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 84
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 83
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 83
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 82
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 82
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 82
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 81
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 80
First-line chemotherapy in over-70 patients with colon cancer. 80
Capecitabine in elderly patients with metastatic breast cancer 80
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 80
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 79
Capecitabine in elderly breast cancer patients 79
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report 79
Clinical Review on the Management of Breast Cancer Visceral Crisis 77
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 77
Dietary chemoprevention of colorectal cancer 77
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 75
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 75
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 74
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 74
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 74
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 74
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 74
Opportunities and Challenges of Synthetic Data Generation in Oncology 73
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 73
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 73
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 73
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 72
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 72
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 71
The therapeutic potential of duloxetine in prostate cancer-related fatigue 70
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 70
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 69
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 69
Never too old to fight breast cancer 68
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 68
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 68
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 67
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 67
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 67
Trabectedin for the treatment of soft tissue sarcoma 67
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 64
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 63
Trabectedin for the treatment of soft tissues sarcomas 63
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 63
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 63
Imatinib mesylate in desmoplastic small round cell tumors 62
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 62
Never too old to fight breast cancer: A case report 62
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 62
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 61
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 60
Sporadic desmoid tumors of the abdominal wall: the results of surgery 60
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 60
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 60
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen 59
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis 59
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 58
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 58
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 57
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 56
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 56
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 55
Profiling the Spectrum of Headache Disorders on 440 Breast Cancer Patients: Highlights on Clinical and Pathological Mechanisms 54
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 54
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 54
[Integrated treatment of breast cancer: review of our experience] 53
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer 53
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 51
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib 50
Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities 49
Totale 7.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022413 0 2 15 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024779 54 63 164 34 30 110 52 32 8 21 67 144
2024/20251.215 27 3 4 11 15 173 51 118 216 276 151 170
2025/20263.821 486 621 236 419 154 150 825 170 216 212 105 227
2026/2027570 345 225 0 0 0 0 0 0 0 0 0 0
Totale 8.759